Sign up to save your podcasts
Or
Share A call to action: Global Blood Therapeutics on tackling orphan disease
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
A call to action: Global Blood Therapeutics on tackling orphan disease
What does it take to tackle the most perplexing orphan diseases? Ted W. Love, M.D., President and CEO, Global Blood Therapeutics (GBT), speaks with RBC Capital Markets’ Senior Biotechnology Analyst Gregory Renza, M.D., about having a mission and the drive to succeed on this episode of Pathfinders.
View all episodes
By RBC Capital Markets
5
1212 ratings
What does it take to tackle the most perplexing orphan diseases? Ted W. Love, M.D., President and CEO, Global Blood Therapeutics (GBT), speaks with RBC Capital Markets’ Senior Biotechnology Analyst Gregory Renza, M.D., about having a mission and the drive to succeed on this episode of Pathfinders.
More shows like Pathfinders in Biopharma
View all
The Bill Simmons Podcast
30,045 Listeners
RBC's Markets in Motion
40 Listeners
Industries in Motion
10 Listeners
Powering Sustainable Ideas
0 Listeners
The Rest Is Politics
3,248 Listeners
Macro Minutes
3 Listeners
Strategic Alternatives
17 Listeners
The Rest Is Politics: US
2,238 Listeners